Evofem Biosciences Funding & Investors
Evofem Biosciences, Inc. operates as a clinical-stage specialty biopharmaceutical company. The Company focuses on women's medical needs through development and commercialization of women's healthcare products. Evofem Biosciences develops therapeutic solutions to meet sexual and reproductive health needs. Evofem Biosciences serves patients in the United States.
evofem.comTotal Amount Raised: $175,300,000
Evofem Biosciences Funding Rounds
Post Ipo Equity
$50,000,000
Post Ipo Equity Investors
Pdl BiopharmaPost Ipo Equity
$10,000,000
Post Ipo Equity Investors
Keystone CapitalPost Ipo Debt
$25,000,000
Post Ipo Debt Investors
Adjuvant CapitalPost Ipo Equity
$30,000,000
Post Ipo Equity Investors
Pdl BiopharmaSeries C
$6,700,000
Series C Investors
RUSNANOMirae Asset Venture InvestmentSeries C
$20,600,000
Series C Investors
RUSNANOAMOREPACIFIC VenturesDomain AssociatesNumoda Capital InnovationsAlta PartnersRMI PartnersPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
Woodford Investment ManagementSeries C
$8,000,000
Series C Investors
Alta PartnersAK CapitalDomain Associates
Funding info provided by Diffbot.